{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:37:48Z","timestamp":1762508268249,"version":"3.37.3"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Great Ormond Street Hospital NHS Foundation Trust and UCL Great Ormond Street Institute of Child Health"},{"DOI":"10.13039\/501100019256","name":"NIHR Great Ormond Street Hospital Biomedical Research Centre","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100019256","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>The objectives of this study were (i) to describe the clinical presentation, treatment and outcome of paediatric inflammatory multisystem syndrome temporally related to Sars-CoV-2 (PIMS-TS) in children; (ii) to propose a framework to guide multidisciplinary team (MDT) management; and (iii) to highlight the role of the paediatric rheumatologist in this context.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This study involved a retrospective case notes review of patients referred to a single specialist paediatric centre with suspected PIMS-TS, with a focus on clinical presentation, laboratory parameters, treatment, and outcome in the context of an MDT framework.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Nineteen children of median age 9.1\u2009years fulfilled the definition of PIMS-TS and were managed within an MDT framework: 5\/19 were female; 14\/19 were of Black, Asian or minority ethnicity; 9\/19 also fulfilled diagnostic criteria for complete or incomplete Kawasaki disease (KD). Severe systemic inflammation, shock, and abdominal pain were ubiquitous. Treatment was stratified within an MDT framework and included CSs in all; i.v. immunoglobulin\u00a0in all; anakinra in 4\/19; infliximab in 1\/19; and antiviral (aciclovir) in 4\/19.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>We observed significant diagnostic equipoise using a current definition of PIMS-TS, overlapping with KD. Outside of clinical trials, an MDT approach is vital. The role of the paediatric rheumatologist is to consider differential diagnoses of hyperinflammation in the young, to advise on empiric immunomodulatory therapy, to set realistic therapeutic targets, to gauge therapeutic success, to oversee timely step-down of immunomodulation, and to contribute to the longer-term MDT follow-up of any late inflammatory sequelae.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa652","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T19:14:29Z","timestamp":1600888469000},"page":"911-917","source":"Crossref","is-referenced-by-count":8,"title":["Management of severe hyperinflammation in the COVID-19 era: the role of the rheumatologist"],"prefix":"10.1093","volume":"60","author":[{"given":"Charalampia","family":"Papadopoulou","sequence":"first","affiliation":[{"name":"Department of Paediatric Rheumatology, London, UK"},{"name":"Infection, Inflammation and Rheumatology Section, London, UK"},{"name":"NIHR Biomedical Research Centre, UCL Great Ormond Street Institute of Child Health, Great Ormond Street Hospital NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muthana","family":"Al Obaidi","sequence":"additional","affiliation":[{"name":"Department of Paediatric Rheumatology, London, UK"},{"name":"Infection, Inflammation and Rheumatology Section, London, UK"},{"name":"NIHR Biomedical Research Centre, UCL Great Ormond Street Institute of Child Health, Great Ormond Street Hospital NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Moraitis","sequence":"additional","affiliation":[{"name":"Department of Paediatric Rheumatology, London, UK"},{"name":"Infection, Inflammation and Rheumatology Section, London, UK"},{"name":"NIHR Biomedical Research Centre, UCL Great Ormond Street Institute of Child Health, Great Ormond Street Hospital NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine\u00a0","family":"Compeyrot-Lacassagne","sequence":"additional","affiliation":[{"name":"Department of Paediatric Rheumatology, London, UK"},{"name":"NIHR Biomedical Research Centre, UCL Great Ormond Street Institute of Child Health, Great Ormond Street Hospital NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Despina","family":"Eleftheriou","sequence":"additional","affiliation":[{"name":"Department of Paediatric Rheumatology, London, UK"},{"name":"Infection, Inflammation and Rheumatology Section, London, UK"},{"name":"NIHR Biomedical Research Centre, UCL Great Ormond Street Institute of Child Health, Great Ormond Street Hospital NHS Foundation Trust, London, UK"},{"name":"Centre for Adolescent Rheumatology Versus Arthritis, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Brogan","sequence":"additional","affiliation":[{"name":"Department of Paediatric Rheumatology, London, UK"},{"name":"Infection, Inflammation and Rheumatology Section, London, UK"},{"name":"NIHR Biomedical Research Centre, UCL Great Ormond Street Institute of Child Health, Great Ormond Street Hospital NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,11,16]]},"reference":[{"key":"2021020119163406300_keaa652-B1","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(20)31094-1","article-title":"Hyperinflammatory shock in children during COVID-19 pandemic","volume":"395","author":"Riphagen","year":"2020","journal-title":"Lancet"},{"key":"2021020119163406300_keaa652-B2","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(20)31103-X","article-title":"An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study","volume":"395","author":"Verdoni","year":"2020","journal-title":"Lancet"},{"key":"2021020119163406300_keaa652-B3","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/rheumatology\/key344","article-title":"European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease \u2013 the SHARE initiative","volume":"58","author":"de Graeff","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2021020119163406300_keaa652-B4","doi-asserted-by":"crossref","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"year":"2020","key":"2021020119163406300_keaa652-B5"},{"key":"2021020119163406300_keaa652-B6","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.autrev.2018.01.024","article-title":"The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: a retrospective cases series","volume":"17","author":"Kone-Paut","year":"2018","journal-title":"Autoimmun Rev"},{"key":"2021020119163406300_keaa652-B7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/art.39975","article-title":"Review: found in translation: international initiatives pursuing interleukin-1 blockade for treatment of acute Kawasaki Disease","volume":"69","author":"Burns","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2021020119163406300_keaa652-B8","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1086\/428291","article-title":"Association between a novel human coronavirus and Kawasaki disease","volume":"191","author":"Esper","year":"2005","journal-title":"J Infect Dis"},{"key":"2021020119163406300_keaa652-B9","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0140-6736(94)92154-7","article-title":"Active or recent parvovirus B19 infection in children with Kawasaki disease","volume":"343","author":"Nigro","year":"1994","journal-title":"Lancet"},{"key":"2021020119163406300_keaa652-B10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1086\/498875","article-title":"Lack of association between infection with a novel human coronavirus (HCoV), HCoV-NH, and Kawasaki disease in Taiwan","volume":"193","author":"Chang","year":"2006","journal-title":"J Infect Dis"},{"key":"2021020119163406300_keaa652-B11","doi-asserted-by":"crossref","first-page":"7952","DOI":"10.1073\/pnas.1400380111","article-title":"Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to Japan","volume":"111","author":"Rodo","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021020119163406300_keaa652-B12","doi-asserted-by":"crossref","first-page":"e0191087","DOI":"10.1371\/journal.pone.0191087","article-title":"Environmental epidemiology of Kawasaki disease: linking disease etiology, pathogenesis and global distribution","volume":"13","author":"Manlhiot","year":"2018","journal-title":"PLoS One"},{"year":"2020","key":"2021020119163406300_keaa652-B13"},{"key":"2021020119163406300_keaa652-B14","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jpeds.2011.05.013","article-title":"Coronary artery dilation in sickle cell disease","volume":"159","author":"Nicholson","year":"2011","journal-title":"J Pediatr"},{"key":"2021020119163406300_keaa652-B15","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.006979","article-title":"Relationship of echocardiographic Z scores adjusted for body surface area to age, sex, race, and ethnicity: the Pediatric Heart Network normal echocardiogram database","volume":"10","author":"Lopez","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"2021020119163406300_keaa652-B16","first-page":"474","article-title":"An insertion unique to SARS-CoV-2 exhibits superantigenic character strengthened by recent mutations","volume":"16","author":"Cheng","journal-title":"Bioinformation"},{"key":"2021020119163406300_keaa652-B17","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/jpc.15049","article-title":"Update on the COVID-19-associated inflammatory syndrome in children and adolescents; paediatric inflammatory multisystem syndrome-temporally associated with SARS-CoV-2","volume":"56","author":"Singh-Grewal","year":"2020","journal-title":"J Paediatr Child Health"},{"key":"2021020119163406300_keaa652-B18","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"2021020119163406300_keaa652-B19","doi-asserted-by":"crossref","first-page":"2001634","DOI":"10.1183\/13993003.01634-2020","article-title":"Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?","volume":"56","author":"Huertas","year":"2020","journal-title":"Eur Respir J"},{"key":"2021020119163406300_keaa652-B20","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1002\/sim.6225","article-title":"Bayesian methods for the design and interpretation of clinical trials in very rare diseases","volume":"33","author":"Hampson","year":"2014","journal-title":"Stat Med"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/2\/911\/36168026\/keaa652.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/2\/911\/36168026\/keaa652.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T04:22:43Z","timestamp":1612326163000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/2\/911\/5983715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,16]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,11,16]]},"published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa652","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"type":"print","value":"1462-0324"},{"type":"electronic","value":"1462-0332"}],"subject":[],"published-other":{"date-parts":[[2021,2,1]]},"published":{"date-parts":[[2020,11,16]]}}}